Hashimoto's encephalopathy (HE) is a well-established disease that occurs most commonly in patients with euthyroidism. We report 3 patients diagnosed with HE. Cases 1 and 2 were young females who had experienced intractable seizures and presented with cognitive impairment. Reversible slow waves on the electroencephalogram (EEG), and nearly complete recovery of cognition, were noted after steroid treatment. Case 3 was an elderly male who presented with a sudden onset of vertigo, diplopia, and recurrent gait ataxia. 
Introduction
Hashimoto's encephalopathy (HE) is a distinct clinical entity appearing most often with euthyroidism or mild subclinical hypothyroidism. Clinical features of HE clearly differ from those of typical myxedematous encephalopathy. Diagnosis of HE requires exclusion of other causes of encephalopathy, such as infection, metabolic, toxic, neoplastic, paraneoplastic, or vascular causes. The clinical expression includes focal neurologic deficits, diffuse encephalopathy with hypertonia, tremor, myoclonus, choreoathetosis, complex-partial or generalized seizures, and frontotemporal neuropsychologic dysfunction. Reversible slowing on the electroencephalogram (EEG), and hypoperfusion on single photon emission computed tomography (SPECT), have been reported in the literature. 1, 2 We report 3 patients with HE, with reversible EEG or SPECT abnormalities after treatment with steroids or in combination with levothyroxine. We also review 25 cases of HE in the literature and compare their characteristics with ours.
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Case 1
A 21-year-old female had some visual hallucinations at age 17 years. These disappeared completely approximately 2 weeks later without treatment.
Two weeks before admission to our hospital, the patient developed auditory hallucinations with impaired cognition. Cerebrospinal fluid (CSF) study at another hospital revealed a red blood cell count (RBC) of 181/mm 3 , white blood cell count (WBC) of 7/mm normal. Seizures developed during hospitalization and the patient's mental state continued to deteriorate. Two days later, she became agitated, confused and, finally, bedridden. The patient was brought to our hospital, and neurologic examination revealed drowsy consciousness, generalized rigidity, increased deep-tendon and flexor-plantar reflexes. CSF study revealed an RBC of 315/mm 3 , a WBC of 2/mm 3 , a protein level of 37 mg/dL, and a normal glucose level. Microbiologic study of CSF was normal. Phenytoin was prescribed for recurrent generalized tonic-clonic seizures. An EEG revealed poor alpha rhythms and frequent, diffuse, random, polymorphic theta waves.
99m Tc hexamethylpropyleneamine oxime (HMPAO) brain SPECT and thyroid function were normal. Brain magnetic resonance imaging (MRI) disclosed focal high-signal intensity on T2-weighted imaging (T2WI) and fluidattenuated inversion recovery (FLAIR) images at the right posteroinferior aspect of the cerebellar hemisphere and vermis without significant contrast enhancement. Acyclovir was prescribed for possible herpes encephalitis. Autoimmune studies, including serum antinuclear antibodies (ANA) and anticardiolipid antibodies (ACA), were normal. As central nervous system (CNS) vasculitis was suspected, intravenous dexamethasone 5 mg every 8 hours was given on day 4.
Unfortunately, aspiration pneumonia developed with respiratory failure and the patient was admitted to the intensive care unit on day 6. A repeated CSF study on day 8 revealed an RBC of 29/mm 3 , a WBC of 1/mm 3 , a protein level of 15 mg/dL, and a normal glucose level. An elevated CSF immunoglobulin-G index (IGGI) of 0.62 was noted, but no oligoclonal bands were present. Dexamethasone was prescribed for only 12 days because pneumonia did not improve.
On the day of discharge, after nearly 3 months of hospitalization, the patient could walk for about 300 meters. A follow-up EEG study 3 months later revealed well-organized alpha activity, although the activity decreased in the left temporal lobe. Follow-up MRI 5 months later revealed no residual high-signal lesions in the right cerebellar hemisphere on T2WI. However, the patient still became agitated intermittently, with visual hallucinations and slurred speech. Tremors and myoclonic jerks over all 4 limbs were also present. Antithyroid autoantibodies were surveyed and revealed an elevated level of antithyroid peroxidase (anti-TPO) antibody (100 IU/mL; normal < 35 IU/mL). Antithyroglobulin (anti-TG) antibody level was normal. HE was diagnosed and oral prednisolone 60 mg/day was prescribed. The patient's cognition improved and she became much less agitated. An EEG after 5 months of steroid treatment disclosed only residual focal slow waves in the left temporo-occipital lobe. The patient's mental function recovered completely without seizures or hallucinations after 9 months of steroid therapy.
Case 2
A 25-year-old female, who was about to be married, experienced progressive deterioration of consciousness for 8 days. Before that, she had been happily preparing for her wedding. On November 10, 2001, she began talking to herself. During these episodes, she repeated the same words over and over. She underwent examination at another hospital, but no definite diagnosis was made. Her cognition gradually worsened and she was brought to our hospital on November 19, 2001. She appeared agitated and shouted continuously. She presented generalized rigidity without focal weakness. Normal deep-tendon and flexor-plantar reflexes were present. Brain MRI was normal and CSF study revealed an RBC of 12/mm 3 , WBC of 6/mm 3 , (neutrophil: lymphocyte ratio of 4:2), glucose level of 71 mg/dL, and a protein level of 42 mg/dL. An EEG suggested a hypersomnolent state with symmetrical sleep spindles and rare slow waves. Intravenous acyclovir 500 mg every 8 hours was prescribed for 10 days, beginning on November 21, 2001, due to suspicion of herpes encephalitis. Two days later, further CSF study disclosed an elevated IGGI of 0.7 and positive oligoclonal bands. Other microbiologic studies of CSF, which included tests for syphilis, fungus, cryptococcus, tuberculosis, and polymerase chain reaction (PCR) testing for both enterovirus and herpes virus, were all negative. Serum ANA were present with a speckled pattern and titer of 1:160. Levels of thyroid stimulation hormone (TSH) and free thyroxine were normal, but high levels of anti-TG antibodies (1,209 IU/mL) and anti-TPO antibodies (448 IU/mL) were present.
Other autoimmune titers including anti-doublestrand-DNA antibodies, ACA, lupus-anticoagulant (LA), anti-Sjögren's syndrome A antibodies (SSA), anti-Sjögren's syndrome B antibodies (SSB), and antineutrophil cytoplasmic antibodies (ANCA), were negative. Intravenous hydrocortisone was prescribed. 
Case 3
A 68-year-old male experienced a sudden onset of vertigo and unsteadiness on July 22, 2001. Neurologic examination suggested intact mentality and consciousness, but diplopia was noted with ataxic gait. Brain MRI disclosed multiple high-signal spots in bilateral subcortical white matter on T2WI. An inflammatory process in the CNS was suspected. CSF study disclosed a normal cell count, an elevated protein level of 83 mg/dL, and a normal glucose level. CSF IGGI was normal, without oligoclonal bands.
99m Tc HMPAO SPECT revealed decreased uptake in the upper portion of the left cerebellum. Because cerebellitis was suspected, steroids were prescribed and gait ataxia gradually improved. Tc HMPAO SPECT was performed 2 weeks later, after steroid treatment, and revealed improved perfusion of the previously hypoperfused area. The patient was discharged with a prescription for oral prednisolone 30 mg/day and was followed-up at an outpatient clinic.
Unfortunately, 2 months later, vertigo and gait ataxia recurred after tapering of steroids.
99m
Tc HMPAO SPECT revealed decreased perfusion in the left basal ganglion and left temporal area. Steroids were prescribed again and the patient's symptoms improved. Five months later, vertigo recurred and consciousness deteriorated over 2 days. Visual hallucinations also occurred. A brain CT scan revealed possible left basal ganglion infarction and edematous change of the left cerebellar hemisphere. An EEG disclosed generalized asynchronous polymorphic theta and delta waves with background slowing. CSF study revealed a normal cell count, and normal protein and glucose levels. Other laboratory data included TSH 50.8 µIU/mL (normal, 0.4-4.0 µIU/mL), and free thyroxine < 2 pg/mL (normal, 7-19 pg/mL). The anti-TPO antibody level was more than 1,000 IU/mL. Thyroid sonography disclosed generalized heteroechogenicity compatible with Hashimoto's thyroiditis. Levothyroxine was prescribed without steroids, and the patient gradually regained consciousness. He was discharged 2 weeks later. In the following 8 months, he remained stable, with only mild ataxia and without cognitive impairment, during levothyroxine therapy.
Discussion
Clinically, suspicion of HE arises from the presence of cognitive impairment or focal neurologic deficit, the presence of antithyroid autoantibodies, and the exclusion of infective, metabolic, toxic, neoplastic, paraneoplastic and vascular causes. Two types of HE have been proposed by Kothbauer-Margreiter et al. 7 The first is vasculitic (type I) and is characterized by strokelike episodes with transient focal neurologic deficits with or without cognitive impairment and confusion, sometimes in combination with epileptic seizures. Its course is relapsing-remitting with symptomless intervals. The second is diffuse-progressive (type II) and has an insidious onset and a progressively deteriorating course without focal neurologic signs. Brisk tendon reflexes and pyramidal tract signs are frequently found. Patients with the diffuse-progressive type may become confused, psychotic, somnolent or comatose. Seizure disorders are regularly present.
Cases 1 and 2, both young females, presented with diffuse cognitive impairment, including hallucinations, disorientation, delirium, and self-talk. Both patients had hypertonicity and recurrent seizures, which were resistant to anticonvulsants. Both had euthyroidism, and the diagnosis of HE was made based on impaired cognition, the presence of antithyroid autoantibodies, and the response to steroid therapy. These 2 clinical presentations were similar to the diffuse-progressive type of HE. Both patients had complete remission and reversible EEG abnormalities after steroid treatment.
In our review of the literature, EEG findings in HE patients varied considerably. Diffuse slow waves, which predominantly involved frontal-temporal areas, were the most common finding and were present in 89.2% of patients. The EEG in case 1 showed diffuse random polymorphic theta waves, which initially recovered to well-organized alpha activity before steroid treatment, with only residual focal slow waves present in the left temporo-occipital lobe after steroid treatment. Case 2 presented symmetrical sleep spindles and rare slow waves. Improvement in cognition was noted earlier than improvement in the EEG presentation. The EEG returned to normal at 1-year follow-up. Case 3 was an elderly male classified as having the vasculitic type of HE. No seizures were noted. The diagnosis of HE was made due to the presence of diplopia, ataxia, the presence of serum antithyroid autoantibodies, and the response to steroid therapy. The patient had 3 episodes of attacks. He recovered cognition, although mild ataxia persisted. In our literature review, 3 of 4 patients with SPECT studies had decreased cerebral perfusion and 2 of them had reversible hypoperfusion. Forchetti et al reported an HE patient with diffuse and homogeneous cerebral hypoperfusion on SPECT, which normalized after steroid treatment. 2 Our case 3 underwent a series of 99m Tc HMPAO SPECT studies, which also disclosed reversible hypoperfusion in the left cerebellar hemisphere after steroid treatment.
Our literature review (Table 1 ) revealed a mean age of 44 years with a wide age range (12-77 years), and 89.2% of cases were female. Both types of HE have favorable prognosis if treatment is started early, although type II patients appear to have a more favorable prognosis than type I patients. Fifteen patients (53.5%) were type I and 13 patients (46.4%) were type II; 7 type I patients (46.6%) and 9 type II patients (69.2%) experienced complete remission. The poorer outcome of type I patients might be due to attacks recurrently involving the same cerebral structures. Our case 3 had recurrent attacks of the left cerebellar hemisphere that resulted in residual ataxia.
In 1995, a female patient was reported with HE in Taiwan; 5 the clinical picture and EEG slowing were similar to those in our first 2 cases. The patient had subclinical hypothyroidism related to Hashimoto's thyroiditis. However, CSF and brain imaging studies were normal in this case, and thus different from ours. In our review of the literature, HE most commonly affected patients with euthyroidism ( central effects of excessive thyrotropin-releasing hormone, and an unidentified common antigen between the brain and the thyroid gland. 15 The most probable pathogenesis of HE is vasculitis, which is supported by two histopathologic studies.
9, 16 Shibata et al reported a patient with an MRI finding of high-signal intensity in the left parieto-occipital lobe on T2WI. 16 This patient also showed angiitis and lymphocyte infiltration of the entire wall of small parenchymal vessels, both arterioles and venules, in a histopathologic examination. In 2000, Nolte et al reported histopathologic data for a patient, which disclosed prominent infiltration of lymphocytes within leptomeningeal vessel walls. 9 The role of antithyroid antibodies has often been debated, since they are found in 10% of normal healthy humans. 3 The pathogenetic role of antithyroid autoantibodies has not been established, because such autoantibodies in CSF were detectable in only 1 patient. 3 Nevertheless, such autoantibodies are now regarded as indicators of HE.
HE is a well-established, distinct clinical entity that responds to steroid treatment. If such treatment is started early, a favorable outcome can be expected in 85.7% of cases, with complete remission or only mild neurologic deficits, such as cognitive impairment, myoclonus, tremors, ataxia and apraxia.
